Eckert & Ziegler Strahlen- und Medizintechnik AG Stock OTC Markets
Equities
EKZRF
DE0005659700
Office Equipment
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -.--% |
May. 15 | ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating | ZD |
May. 14 | Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 271M 290M | Sales 2025 * | 296M 317M | Capitalization | 935M 1B |
---|---|---|---|---|---|
Net income 2024 * | 34M 36.39M | Net income 2025 * | 36M 38.53M | EV / Sales 2024 * | 3.29 x |
Net cash position 2024 * | 43.4M 46.45M | Net cash position 2025 * | 42.6M 45.59M | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
27
x | P/E ratio 2025 * |
25.3
x | Employees | - |
Yield 2024 * |
1.12% | Yield 2025 * |
1.12% | Free-Float | 67.11% |
Latest transcript on Eckert & Ziegler Strahlen- und Medizintechnik AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-12-31 | |
Andreas Eckert
FOU | Founder | 55 | 96-12-31 |
Karolin Riehle
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Edgar Löffler
BRD | Director/Board Member | 71 | 18-12-31 |
Andreas Eckert
FOU | Founder | 55 | 96-12-31 |
Frank Perschmann
BRD | Director/Board Member | 71 | 19-05-28 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.17% | 7.47B | |
-5.77% | 4.66B | |
-1.19% | 3.1B | |
+10.03% | 2.21B | |
-31.24% | 1.05B | |
+3.00% | 895M | |
-48.27% | 817M | |
-28.39% | 702M | |
-23.88% | 677M |
- Stock Market
- Equities
- EUZ Stock
- EKZRF Stock